General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 151: Caspases are involved in:

A. Cell division
B. Necrosis
C. Apoptosis (Correct Answer)
D. Inflammation

Explanation: **Explanation:** **Caspases** (Cysteine-aspartic proteases) are the central executioners of **Apoptosis** (programmed cell death) [1]. They exist as inactive zymogens (pro-caspases) and are activated through a proteolytic cascade [1]. 1. **Why Apoptosis is Correct:** Apoptosis is mediated by two main pathways: the **Intrinsic (Mitochondrial)** and **Extrinsic (Death Receptor)** pathways [1]. Both pathways converge on the activation of caspases [1][2]. * **Initiator Caspases:** Caspase-8 and 9 (and 10) [1]. * **Executioner Caspases:** Caspase-3, 6, and 7. These proteases cleave cellular proteins and activate endonucleases, leading to DNA fragmentation and the characteristic morphological changes of apoptosis [1]. 2. **Why Other Options are Incorrect:** * **Cell Division:** This process is regulated by Cyclins and Cyclin-Dependent Kinases (CDKs), not caspases [3]. * **Necrosis:** This is an accidental, unregulated form of cell death characterized by cell swelling and membrane rupture. It is generally caspase-independent. * **Inflammation:** While Caspase-1 is involved in the "Inflammasome" to process IL-1β (a process called Pyroptosis), the primary and most classic function of the caspase family as a whole is the regulation of Apoptosis [2]. **High-Yield NEET-PG Pearls:** * **Caspase-3** is the most important executioner caspase (the "common point" of both pathways). * **Caspase-8** is associated with the Extrinsic pathway (Fas/FasL) [2]. * **Caspase-9** is associated with the Intrinsic pathway (Cytochrome c release) [1]. * **Marker of Apoptosis:** Annexin V (binds to phosphatidylserine on the outer membrane). * **DNA Laddering:** A hallmark of apoptosis seen on electrophoresis due to internucleosomal cleavage by caspases-activated DNase. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-67. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 67. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 80-81.

Question 152: Which of the following is not an example of apoptosis?

A. Graft versus host disease
B. Menstrual cycle
C. Pathological atrophy following duct obstruction
D. Tumor necrosis (Correct Answer)

Explanation: The core distinction between **apoptosis** and **necrosis** lies in the mechanism of cell death. Apoptosis is a programmed, energy-dependent process that can be either physiological or pathological, whereas necrosis is always a pathological process resulting from severe, irreversible cell injury. **Why "Tumor Necrosis" is the correct answer:** Tumor necrosis occurs when a rapidly growing neoplasm outstrips its blood supply, leading to **ischemic coagulative necrosis** [4]. This is a passive, accidental form of cell death characterized by cell swelling, membrane rupture, and an ensuing inflammatory response [2]. In contrast, apoptosis involves cell shrinkage and membrane blebbing without inflammation [2]. **Analysis of Incorrect Options:** * **Graft versus host disease (GVHD):** This is a classic example of **pathological apoptosis**. Cytotoxic T-lymphocytes (CTLs) induce apoptosis in host cells via the Perforin/Granzyme pathway or Fas-Fas ligand interaction [1]. * **Menstrual cycle:** This is a hallmark of **physiological apoptosis** [3]. The withdrawal of hormones (progesterone) triggers the programmed breakdown and shedding of the endometrial lining [3]. * **Pathological atrophy following duct obstruction:** When ducts in organs like the pancreas, parotid gland, or kidney are obstructed, the parenchymal cells undergo **apoptosis** due to pressure and loss of trophic signals. **High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** The most characteristic feature of apoptosis is **chromatin condensation** (pyknosis). * **Caspases:** These are cysteine proteases that serve as the "executioners" of apoptosis. * **Councilman bodies:** These are apoptotic hepatocytes seen in Viral Hepatitis. * **Psammoma bodies:** These represent areas of **dystrophic calcification** following necrosis (not apoptosis). * **Inflammation:** Apoptosis does **not** elicit an inflammatory response, whereas necrosis always does [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 67. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 67-69. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-64. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 69-71.

Question 153: A chronic alcoholic presents with elevated serum alpha-fetoprotein levels. Which of the following neoplasms is most likely?

A. Prostatic adenocarcinoma
B. Multiple myeloma
C. Hepatocellular carcinoma (Correct Answer)
D. Glioblastoma multiforme

Explanation: **Explanation:** The correct answer is **Hepatocellular Carcinoma (HCC)**. **1. Why HCC is correct:** Alpha-fetoprotein (AFP) is a glycoprotein normally produced by the fetal yolk sac and liver. In adults, it serves as a highly specific **tumor marker** for certain neoplasms [1]. Chronic alcoholism is a leading cause of liver cirrhosis [2], which is the strongest predisposing factor for the development of HCC [3]. When a patient with a history of chronic alcohol abuse presents with elevated AFP, it strongly suggests malignant transformation of hepatocytes [1]. **2. Why the other options are incorrect:** * **Prostatic Adenocarcinoma:** The primary tumor marker is **Prostate-Specific Antigen (PSA)**. AFP is not associated with prostate cancer. * **Multiple Myeloma:** This is a plasma cell dyscrasia characterized by **M-protein spikes** on serum protein electrophoresis and Bence-Jones proteins in urine. * **Glioblastoma Multiforme:** This is a high-grade glial tumor of the CNS. It does not secrete serum AFP; diagnosis is typically via imaging (ring-enhancing lesions) and biopsy (pseudopalisading necrosis). **3. NEET-PG High-Yield Pearls:** * **AFP Cut-off:** While mild elevations occur in cirrhosis/hepatitis, levels **>400-500 ng/mL** in a high-risk patient are highly suggestive of HCC. * **Other AFP-positive tumors:** Yolk sac tumors (Endodermal sinus tumors) and certain Germ Cell Tumors (GCTs). * **Screening:** Patients with cirrhosis should be screened for HCC every 6 months using **Ultrasound + Serum AFP** [1]. * **Fibrolamellar variant of HCC:** Important exception—it usually occurs in young adults without cirrhosis and typically has **normal AFP levels**. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-389. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 223-224.

Question 154: Type IV Ehlers-Danlos syndrome is characterized by which of the following?

A. Deficiencies in hydroxylase and lysyl oxidase.
B. Decreased amount of type III collagen. (Correct Answer)
C. Nonfunctioning plasma fibronectin.
D. All of the above.

Explanation: **Explanation:** Ehlers-Danlos Syndrome (EDS) is a clinically and genetically heterogeneous group of disorders resulting from defects in the synthesis or structure of fibrillar collagen [1]. **Why Option B is Correct:** Type IV EDS, also known as the **Vascular Type**, is caused by mutations in the **COL3A1 gene**. This gene encodes the pro-alpha1 chains of **Type III collagen**. The mutation leads to a significantly decreased amount of normal Type III collagen or the production of defective Type III collagen. Since Type III collagen is a major structural component of blood vessels and hollow organs (like the bowel and uterus), this subtype is characterized by life-threatening arterial rupture and visceral perforation [1]. **Why Other Options are Incorrect:** * **Option A:** Deficiencies in lysyl hydroxylase are characteristic of **Type VI EDS (Kyphoscoliotic Type)**, which presents with ocular fragility and severe hypotonia. Lysyl oxidase deficiency is associated with Menkes disease, not typically EDS. * **Option C:** Fibronectin defects are not the primary underlying pathology in the classic or vascular forms of EDS. EDS is fundamentally a collagenopathy. * **Option D:** Since Options A and C are incorrect, "All of the above" is invalid. **High-Yield NEET-PG Pearls:** * **Classic EDS (Types I/II):** Defect in **Type V collagen** (COL5A1, COL5A2); features skin hyperextensibility and "cigarette paper" scarring [1]. * **Vascular EDS (Type IV):** Defect in **Type III collagen**; most serious form due to risk of **aortic rupture** [1]. * **Kyphoscoliotic EDS (Type VI):** Defect in **Lysyl hydroxylase**; look for "retinal detachment" and "kyphoscoliosis" in the stem. * **Arthrochalasia/Dermatosparaxis EDS (Type VII):** Defect in the conversion of Type I procollagen to collagen. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 154-156.

Question 155: The degradation of intracellular organelles through the process in which autosomes combine with primary lysosomes of the cells is called as?

A. Heterophagy
B. Heteroplasmy
C. Autophagy (Correct Answer)
D. Endocytosis

Explanation: **Explanation:** **Autophagy** (from the Greek *auto* "self" and *phagein* "to eat") is a highly regulated evolutionary mechanism where a cell digests its own components [1]. In this process, intracellular organelles (like mitochondria or ER) are sequestered within a double-membrane vesicle called an **autophagosome** [1], [2]. This vesicle then fuses with a **primary lysosome** to form an **autophagolysosome**, where lysosomal enzymes degrade the contents [1]. This serves as a survival mechanism during nutrient deprivation and helps clear damaged organelles [1]. **Why other options are incorrect:** * **Heterophagy:** This refers to the digestion of materials ingested from the *extracellular* environment (e.g., bacteria engulfed by neutrophils) via endocytosis or phagocytosis. * **Heteroplasmy:** A genetic term referring to the presence of more than one type of organellar genome (mitochondrial DNA) within a single cell or individual. It is not a degradative process. * **Endocytosis:** A general term for the uptake of external fluids or macromolecules into the cell via vesicle formation (includes pinocytosis and receptor-mediated endocytosis). **High-Yield Clinical Pearls for NEET-PG:** * **Marker Gene:** **LC3** (Microtubule-associated protein 1 light chain 3) is a key marker used to identify autophagosomes. * **Regulation:** Autophagy is inhibited by **mTOR** (mechanistic target of rapamycin) and activated by **AMPK**. * **Clinical Link:** Deficiencies in autophagy genes (e.g., *ATG* genes) are linked to neurodegenerative diseases (Alzheimer’s, Parkinson’s) and Crohn’s disease. * **Chaperone-mediated autophagy:** A specific subtype where proteins are directly shuttled across the lysosomal membrane without vesicle formation, involving the **Hsp70** chaperone. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 71-73. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 241-242.

Question 156: Amyloidosis is associated with which of the following?

A. Chromosome 21q (Correct Answer)
B. Chromosome 22q
C. Y chromosome
D. Chromosome 17q

Explanation: **Explanation:** The correct answer is **Chromosome 21q**. Amyloidosis refers to the extracellular deposition of misfolded proteins in a β-pleated sheet configuration [3]. The association with Chromosome 21 is specifically linked to **Alzheimer’s Disease** and **Down Syndrome (Trisomy 21)** [1]. The gene encoding the **Amyloid Precursor Protein (APP)** is located on the long arm of **Chromosome 21 (21q21.3)** [1]. In patients with Down Syndrome, the extra copy of this gene leads to an overexpression of APP, which is subsequently cleaved into **Aβ (Amyloid Beta) peptides** [2]. This results in the premature deposition of cerebral amyloid plaques, explaining why almost all Down Syndrome patients develop Alzheimer-like pathology by age 40 [2]. **Analysis of Incorrect Options:** * **Chromosome 22q:** Associated with DiGeorge syndrome (22q11.2 deletion) and NF2 (Neurofibromatosis type 2). It is not the primary locus for systemic or cerebral amyloid proteins. * **Y chromosome:** Primarily carries genes for male sex determination (SRY gene); it has no known association with amyloidogenic proteins. * **Chromosome 17q:** Associated with the **BRCA1** gene (breast/ovarian cancer) and **NF1** (Neurofibromatosis type 1). While the Tau protein gene (MAPT) is on 17q, the core amyloid protein (APP) is on 21. **NEET-PG High-Yield Pearls:** * **Staining:** Amyloid shows **Apple-green birefringence** under polarized light after **Congo Red** staining. * **AL Amyloid:** Derived from Immunoglobulin Light Chains (associated with Multiple Myeloma) [4]. * **AA Amyloid:** Derived from Serum Amyloid-Associated protein (associated with chronic inflammation like TB or Rheumatoid Arthritis). * **Transthyretin (TTR):** Mutated in Familial Amyloid Polyneuropathies; wild-type in Senile Systemic Amyloidosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1290-1292. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 719-721. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-266. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 135-136.

Question 157: What is the principal mediator of vasodilation in acute inflammation?

A. Serotonin
B. IL-1
C. Histamine (Correct Answer)
D. TNF

Explanation: **Explanation:** **1. Why Histamine is the Correct Answer:** In the early stages of acute inflammation, **vasodilation** is one of the earliest hemodynamic changes [2]. **Histamine** is considered the principal mediator of this immediate phase [1]. It is pre-formed and stored in the granules of **mast cells** (primary source), basophils, and platelets. Upon release, it binds to **H1 receptors** on microvascular endothelial cells, leading to arteriolar dilation and increased capillary permeability (forming endothelial gaps) [1], [4]. This results in the classic "rubor" (redness) and "calor" (heat) of inflammation [5]. **2. Why Other Options are Incorrect:** * **Serotonin (Option A):** While serotonin (5-hydroxytryptamine) is a vasoactive amine similar to histamine, it is primarily found in platelets. Its role in human vasodilation during inflammation is much less significant than histamine; it primarily acts as a vasoconstrictor in other contexts [3]. * **IL-1 and TNF (Options B & D):** Interleukin-1 and Tumor Necrosis Factor are major **pro-inflammatory cytokines** produced by activated macrophages. Their primary roles include inducing systemic acute-phase responses (fever), stimulating the expression of endothelial adhesion molecules (E-selectin, ICAM-1), and leukocyte activation [1]. They do not act as primary, immediate-acting vasodilators. **3. High-Yield Clinical Pearls for NEET-PG:** * **Sequence of events:** Vasodilation (induced by Histamine/Nitric Oxide) is followed by increased vascular permeability (the hallmark of acute inflammation) [2]. * **Most common mechanism of vascular leakage:** Endothelial cell contraction leading to intercellular gaps in **post-capillary venules** [4]. * **Nitric Oxide (NO):** Another potent vasodilator produced by endothelial cells (eNOS) and macrophages (iNOS) that works alongside histamine. * **Triple Response of Lewis:** Induced by histamine, consisting of Red spot (capillary expansion), Flare (arteriolar dilation), and Wheal (exudation/edema) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 101. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 84-85. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 94-95. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 187-188. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 185-186.

Question 158: Which stain is used to identify Gaucher cells?

A. Periodic Acid Schiff (PAS) (Correct Answer)
B. Von Kossa stain
C. Oil red O
D. Sudan Black B

Explanation: **Explanation:** **Gaucher disease** is the most common lysosomal storage disorder, caused by a deficiency of the enzyme **glucocerebrosidase**. This leads to the accumulation of glucocerebroside (a glycolipid) within the lysosomes of macrophages, transforming them into characteristic **Gaucher cells** [1]. 1. **Why PAS is Correct:** Gaucher cells have a distinct "wrinkled tissue paper" or "crumpled silk" appearance of the cytoplasm [1]. Because the accumulated material is a **glycolipid** (containing carbohydrate moieties), it is strongly **PAS (Periodic Acid Schiff) positive**. This stain highlights the complex carbohydrates within the stored lipid. 2. **Analysis of Incorrect Options:** * **Von Kossa stain:** Used to identify **calcium** deposits (appears black). It is commonly used in conditions like Monckeberg arteriosclerosis or nephrocalcinosis. * **Oil red O:** Used to identify **neutral lipids/triglycerides**. While Gaucher cells contain lipids, the glycolipids are better demonstrated by PAS; Oil red O is typically used on frozen sections for fat emboli or steatosis. * **Sudan Black B:** Primarily used to stain **phospholipids and sterols**. It is a classic stain for identifying myeloblasts in Acute Myeloid Leukemia (AML). **High-Yield Clinical Pearls for NEET-PG:** * **Gaucher Cell Morphology:** Large macrophages with eccentric nuclei and fibrillar, "crumpled silk" cytoplasm [1]. * **Enzyme Marker:** Gaucher cells are also positive for **TRAP (Tartrate-Resistant Acid Phosphatase)**. * **Clinical Triad:** Hepatosplenomegaly, bone involvement (Erlenmeyer flask deformity), and pancytopenia [1]. * **Chitotriosidase:** A plasma marker used to monitor disease activity and response to enzyme replacement therapy. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, p. 163.

Question 159: Which of the following is not a tumor marker?

A. CEA
B. Tyrosinase
C. Human leucocyte antigen A2 (Correct Answer)
D. AFP

Explanation: ### Explanation **Correct Answer: C. Human leucocyte antigen A2 (HLA-A2)** **Why it is the correct answer:** Tumor markers are substances (proteins, enzymes, or hormones) produced by neoplastic cells or by the body in response to cancer, which can be measured in blood, urine, or tissues. **HLA-A2** is a Major Histocompatibility Complex (MHC) Class I molecule found on the surface of almost all nucleated cells [1]. Its primary role is in **immunology** (antigen presentation to T-cells) and transplant matching, not as a marker for malignancy [1]. While certain HLA types are associated with disease predispositions, they are not used as diagnostic or prognostic tumor markers. **Why the other options are incorrect:** * **A. CEA (Carcinoembryonic Antigen):** An oncofetal antigen primarily used as a marker for **Colorectal Carcinoma** [2]. It is also elevated in pancreatic, gastric, and breast cancers [3]. It is most useful for monitoring recurrence. * **B. Tyrosinase:** An enzyme involved in melanin synthesis. It is a highly specific marker for **Malignant Melanoma**, often detected via immunohistochemistry (IHC) to identify amelanotic melanomas. * **D. AFP (Alpha-Fetoprotein):** An oncofetal protein used as a classic marker for **Hepatocellular Carcinoma (HCC)** and **Non-seminomatous germ cell tumors (NSGCT)**, specifically Yolk Sac Tumors [3]. **High-Yield NEET-PG Pearls:** * **Most specific marker for Pancreatic Cancer:** CA 19-9. * **Marker for Ovarian Cancer:** CA-125 (also elevated in endometriosis and PID). * **Marker for Medullary Carcinoma of Thyroid:** Calcitonin. * **Prostate Cancer:** PSA (Prostate Specific Antigen) is organ-specific but not cancer-specific (elevated in BPH and prostatitis) [3]. * **Oncofetal Antigens:** These are expressed during fetal life and "reappear" in malignancies (e.g., CEA, AFP) [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 318-319. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 319-320. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 346.

Question 160: Which of the following represents an example of metastatic calcification?

A. Old foci of tuberculosis in the lymph nodes
B. Mitral valve damaged by rheumatic fever
C. Pulmonary calcification in chronic renal failure (Correct Answer)
D. Breast cancer visible by mammography

Explanation: ### Explanation **Concept Overview:** Pathologic calcification is divided into two types: **Dystrophic** and **Metastatic**. * **Dystrophic calcification** occurs in dead or dying tissues despite normal serum calcium levels. * **Metastatic calcification** occurs in normal tissues due to **hypercalcemia** (elevated serum calcium) or deranged calcium-phosphate metabolism [1]. **Why Option C is Correct:** In **Chronic Renal Failure (CRF)**, secondary hyperparathyroidism occurs due to phosphate retention and hypocalcemia [2]. This leads to a high calcium-phosphate product, causing calcium to deposit in normal tissues. The lungs (pulmonary parenchyma) are a frequent site because the relatively alkaline environment (due to CO₂ excretion) favors calcium precipitation [3]. **Analysis of Incorrect Options:** * **Option A (Old TB foci):** Tuberculosis causes caseous necrosis. Calcification occurring in necrotic tissue is a classic example of **Dystrophic calcification**. * **Option B (Damaged Mitral Valve):** Rheumatic fever causes chronic inflammation and scarring of heart valves. Calcification of these damaged valves is **Dystrophic**. * **Option C (Breast Cancer):** Calcification in malignancies (like Psammoma bodies or necrotic centers in ductal carcinoma in situ) occurs in degenerating or dead tumor cells, representing **Dystrophic calcification** [1]. **NEET-PG High-Yield Pearls:** 1. **Common Sites for Metastatic Calcification:** "Acid-excreting organs" like the **Lungs, Gastric mucosa, and Kidneys** (due to internal alkaline environments) [3]. 2. **Dystrophic Calcification:** Serum calcium is **Normal**; occurs in necrotic/damaged tissue (e.g., Atherosclerotic plaques, Monckeberg’s sclerosis). 3. **Metastatic Calcification:** Serum calcium is **Elevated**; occurs in healthy tissue (e.g., Hyperparathyroidism, Vitamin D toxicity, Bone destruction/Multiple Myeloma) [1], [2]. 4. **Morphology:** On H&E stain, both appear as **basophilic (blue/purple)**, amorphous granular clumps [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 134-135. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 667-668. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free